Ly, 681 cases (91.2 ) were ductal carcinomas and 66 cases (8.8 ) were of other types (lobular, medullary, mucinous, papillary, or tubular carcinoma). Mean age at inclusion time was 45.9 ?9.8 (mean ?SD) years and 31.3 were postmenopausal women (Table 1). Most baseline characteristics did not differ between the ER/PR-negative and -positive groups (all Ps > 0.05; Table 1, some data not shown). Howev
Onents of MetS in ER/PR-negative patients (P for trend = 0.044). This association disappeared when adjusted for adiponectin and HOMA-IR. Conclusions: Adiponectin and HOMA-IR have prognostic significance in breast cancer recurrence and interventions related to these factors may protect against recurrence in ER/PR-negative patients. These findings were not observed in the case of ER/PR-positive pati